Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» STP705
STP705
RNAi Therapeutics Focused Sirnaomics Closes $47 Million Series C Round
CP Wire
Fri, 04/26/19 - 10:06 am
Sriaomics
STP705
cholangiocarcinoma
hepatocellular carcinoma
RNAi
RNAi Therapeutics Focused Sirnaomics Closes $47 Million Series C Round
Fri, 04/26/19 - 10:01 am
Sriaomics
STP705
cholangiocarcinoma
hepatocellular carcinoma
Sirnaomics cleared to start first trial of RNAi lead in cancer
Fierce Biotech
Sat, 08/18/18 - 05:14 pm
gene silencing
Simaomics
RNAi
STP705